THE COMPREHENSIVE STUDY ON ROLE OF MICROBIOME IN AUTOIMMUNE DISEASES

This dissertation investigates the intricate relationship between gut microbiome composition and the pathogenesis and progression of autoimmune diseases, addressing the critical issue of how microbiome dysbiosis contributes to autoimmunity. By employing a comprehensive approach that combines microbiome sequencing data with autoimmune disease biomarkers and clinical patient data, this research elucidates the mechanisms underlying this relationship. Key findings reveal distinct microbial profiles associated with specific autoimmune conditions, highlighting the potential role of particular bacterial taxa in either exacerbating or mitigating disease symptoms. Additionally, the study demonstrates that variations in microbial diversity correlate with clinical outcomes, suggesting that a balanced microbiome may be pivotal in maintaining immune homeostasis. The significance of these findings lies in their potential to inform new therapeutic strategies focused on microbiome modulation, which could enhance the management of autoimmune diseases and improve patient outcomes. Furthermore, the broader implications of this research extend to the field of healthcare by emphasizing the necessity for personalized medicine approaches that consider microbiomic factors, thus paving the way for innovative interventions that target microbial health as a means of disease prevention and treatment. Overall, this work contributes to the growing body of evidence linking the microbiome to autoimmune pathology and underscores the importance of microbiome research in advancing our understanding of complex disease mechanisms.